OXYGENTA PHARMACEUTICAL
|
The Current P/E Ratio of OXYGENTA PHARMACEUTICAL is -16.86.
Share Price | ₹68.5 | Sep 29,2025 |
Market Cap | ₹253.6 Cr | |
Earnings-TTM | ₹-15.0 Cr | TTM-Standalone Results |
Price/Earnings | -16.86x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of OXYGENTA PHARMACEUTICAL
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹253.6 Cr] as on Sep 29,2025
(/) Earnings [ ₹-15.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -16.86x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay -16.86 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of OXYGENTA PHARMACEUTICAL !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PE (Price/Earnings) ratio chart of OXYGENTA PHARMACEUTICAL
PE Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 0x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does OXYGENTA PHARMACEUTICAL 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
OXYGENTA PHARMACEUTICAL | -15.04 | -16.86 | 253.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.66 | 381,686.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 65.59 | 151,241.0 |
CIPLA LTD | 5,406.81 | 22.24 | 120,240.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.61 | 121,339.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.00 | 103,091.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.31 | 101,574.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.53 | 99,843.6 |
LUPIN LTD | 3,722.18 | 23.70 | 88,206.8 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.49 | 63,202.8 |
ABBOTT INDIA LTD | 1,452.29 | 43.38 | 62,994.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs OXYGENTA PHARMACEUTICAL 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -16.86x |
Max industry PE | 65.59x |
Median industry PE | 23.70x |
Average industry PE | 31.51x |
You may also like the below Video Courses